CURIS, INC. Revenue from Contract with Customer, Including Assessed Tax
CURIS, INC. (CRIS) reported Revenue from Contract with Customer, Including Assessed Tax of $2.86 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2019-11-05
- CURIS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-09-30 was $2.86M, a 0.32% increase year-over-year.
- CURIS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-06-30 was $2.09M, a 11.20% decline year-over-year.
- CURIS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-03-31 was $1.77M, a 28.40% decline year-over-year.
- CURIS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2018-09-30 was $2.85M, a 16.49% increase year-over-year.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month |
|---|---|---|---|
| 2019-09-30 | $2.86M 10-Q · filed 2019-11-05 | $4.95M derived: sum of 2 quarters · filed 2019-11-05 | $6.72M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $2.09M 10-Q · filed 2019-08-09 | $3.86M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.77M 10-Q · filed 2019-05-14 | ||
| 2018-09-30 | $2.85M 10-Q · filed 2019-11-05 | $5.21M derived: sum of 2 quarters · filed 2019-11-05 | $7.67M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $2.36M 10-Q · filed 2019-08-09 | $4.83M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $2.47M 10-Q · filed 2019-05-14 | ||
| 2017-09-30 | $2.44M 10-Q · filed 2018-11-01 | $4.50M derived: sum of 2 quarters · filed 2018-11-01 | $6.64M 10-Q · filed 2018-11-01 |
| 2017-06-30 | $2.06M 10-Q · filed 2018-08-02 | $4.19M 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |